Please use this identifier to cite or link to this item: http://hdl.handle.net/10637/7721

Progress towards water-soluble triazole-based selective MMP-2 inhibitors.

Title: Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
Authors : Ramos González, Ana
Martínez Alcázar, María Paz
Zapico Rodríguez, José María
Pascual-Teresa Fernández, Beatriz de
Fabre, Benjamin
Filipiak, Kamila
Keywords: MetaloproteínasAnálisis
Abstract: Water solubility is a key aspect that needs to be addressed to obtain druglike compounds. In an effort to improve the water solubility of our recently reported nanomolar matrix metalloproteinase type 2 (MMP10 2) inhibitors based on triazole-substituted hydroxamates, we synthesized a new series of -sulfone, - tetrahydropyran and -piperidine, -sulfone clicked hydroxamates and determined their inhibitory activities against both MMP-2 and MMP-9. The best results were found for 13e, a water-soluble compound that displays a low nanomolar activity against MMP-2 and is 26-fold less active against MMP9. This finding allowed us to pursue in vitro permeability through Caco-2 monolayer and open the 15 possibility for carrying out further preclinical investigations. Docking and MD simulations have been performed in order to rationalize the biological results. The inhibitory activity of this compound against a panel of ten MMPs was determined showing an interesting MMP-2/MMP-1,-8,-14 selectivity profile. The cytotoxicity and anti-invasive activity of the compounds on highly metastatic human fibrosarcoma tumor cells (HT1080) were determined, showing, at 10 M concentration, a decrease in cell invasiveness up to 20 80 %.
Description: En: Organic and Biomolecular Chemistry. EISSN. 1477-0539. 2013, 11, 6623-6641, doi: 10.1039/c3ob41046c
URI: http://hdl.handle.net/10637/7721
Rights : http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
Issue Date: 26-Sep-2013
Center : Universidad San Pablo-CEU
Appears in Collections:Facultad de Farmacia





Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.